| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.18 | 0.1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |